Skip to content

RNTX RNTX Total Current Assets

Total Current Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$27.21B-11.6%
Gilead Sciences logo
Gilead SciencesGILD
$18.64B+10.3%
AbbVie logo
AbbVieABBV
$33.53B+21.2%
CTO
Citius Oncology, Inc.CTOR
$29.42M+63.1%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$67.58M-18.8%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$91.73M+34.0%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's total current assets?
RNTX (RNTX) reported total current assets of $5.45M in Q1 2026.
How has RNTX's total current assets changed year-over-year?
RNTX's total current assets decreased by 34.5% year-over-year, from $8.33M to $5.45M.
What is the long-term trend for RNTX's total current assets?
Over 5 years (2020 to 2025), RNTX's total current assets has grown at a -23.3% compound annual growth rate (CAGR), from $16.33M to $4.33M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.